THE PROBLEMS ASSOCIATED WITH SWITCHING BRAND-NAME ANTIEPILEPTIC DRUGS TO GENERICS: A FOCUS ON TOPAMAX: A REVIEW OF LITERATURE AND A CASE REPORT

Despite the rather high efficiency of treatment for epilepsy (overall, 65–70 % of patients can achieve remission or show a considerable decrease in the frequency of seizures), there remains a challenge due to the need to use antiepileptic drugs long and regularly: therapy adherence, compliance, trea...

Full description

Bibliographic Details
Published in:	Русский журнал детской неврологии
Main Authors:	K. Yu. Mukhin, O. A. Pylaeva, M. Yu. Bobylova
Format:	Article
Language:	Russian
Published:	ABV-press 2016-08-01
Subjects:	epilepsy antiepileptic drug brand-name drug generic drug bioequivalence efficiency of treatment tolerability of treatment
Online Access:	https://rjdn.abvpress.ru/jour/article/view/152

Similar Items

The concept of: Generic drugs and patented drugs Vs brand name drugs and non-proprietary (generic) name drugs.
by: Karan eThakkar, et al.
Published: (2013-09-01)

Generic substitutions of antiepileptic drugs: Is it possible to put an end to the discussion?
by: E. A. Ushkalova, et al.
Published: (2018-07-01)

THE PROBLEM OF AGGRAVATION OF EPILEPTIC SEIZURES DURING THERAPY WITH ANTIEPILEPTIC DRUGS
by: K. Yu. Mukhin, et al.
Published: (2015-04-01)

Drug interchangeability: Clinical efficacy and safety
by: S. K. Zyryanov, et al.
Published: (2017-06-01)

Efficiency of epilepsy treatment in the Moscow Region under the present-day conditions of drug provision
by: Irina Gennadyevna Rudakova, et al.
Published: (2015-10-01)

Opinions of Czech general practitioners on generic drugs and substitution
by: Dosedel Martin, et al.
Published: (2014-12-01)

USE OF THE NEW ANTIEPILEPTIC DRUG PERAMPANEL (FYCOMPA) IN THE TREATMENT OF EPILEPSY: A REVIEW OF FOREIGN LITERATURE
by: O. A. Pylaeva, et al.
Published: (2015-04-01)

Can Generic Medications Be a Safe and Effective Alternative to Brand-Name Drugs for Cardiovascular Disease Treatment? A Systematic Review and Meta-Analysis
by: Bing Luo, et al.
Published: (2025-03-01)

Comparative analysis of thrombocytopenia incidence in patients treated with generic vs. brand-name linezolid: a cohort study utilizing hospital electronic medical records
by: Zhizhou Wang, et al.
Published: (2025-06-01)

WHAT IS THERAPEUTIC EQUIVALENCE OF GENERIC DRUG AND HOW TO PROVE IT
by: N. P. Kutishenko, et al.
Published: (2016-01-01)

Safety and tolerability of antiepileptic therapy: emphasis on the use of valproates (literature review)
by: O. A. Pylaeva, et al.
Published: (2020-01-01)

Generic drugs: myths, facts, and limitations
by: Antonio Marzo, et al.
Published: (2012-10-01)

Peculiarities of approaches to assessing the interchangeability of antiepileptic drugs
by: E. O. Zhuravleva, et al.
Published: (2018-02-01)

NEW BIOMOLECULAR TARGETS FOR ANTIEPILEPTIC DRUGS
by: T. A. Voronina, et al.
Published: (2016-05-01)

MAJOR PRINCIPLES OF EPILEPSY TREATMENT. ALGORITHM OF SELECTION OF ANTIEPILEPTIC DRUGS
by: K. Yu. Mukhin, et al.
Published: (2015-04-01)

Drug switching in the Netherlands: a cohort study of 20 active substances
by: Pieter J. Glerum, et al.
Published: (2020-07-01)

TREATMENT OF OSTEOPOROSIS: CLINICAL EXPERIENCE IN USING A GENERIC DRU
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-03-01)

TREATMENT OF OSTEOPOROSIS: CLINICAL EXPERIENCE IN USING A GENERIC DRU
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-03-01)

Perampanel in the treatment of drug-resistant epilepsy in children
by: M. Yu. Bobylova, et al.
Published: (2018-01-01)

THE POSPONT RESULTS OF SWITCHING ON TOPIRAMAT GENERICS AT PATIENTS WITH EPILEPSY
by: I. G. Rudakova
Published: (2016-05-01)

Antiepileptic Drugs in Children
by: Burçin Nazlı Karacabey, et al.
Published: (2022-09-01)

Epilepsy, Pregnancy, and Antiepileptic Drugs
by: Betül TEKİN
Published: (2018-01-01)

Epilepsy, Antiepileptic Drugs and Lipid Mechanisms
by: Özden KAMIŞLI, et al.
Published: (2018-01-01)

The problem of choice: original drug or generic? Emphasis on rosuvastatin
by: O. A. Polyakova, et al.
Published: (2022-05-01)

Safety and tolerability of antiepileptic drugs in women with epilepsy (literature review and own data)
by: K. Yu. Mukhin, et al.
Published: (2019-04-01)

Successful generic drug product development: From research to marketing approval
by: Suchart Chongprasert
Published: (2016-02-01)

The problem of choosing between the original and of generic drugs in patients with overweight and obesity
Published: (2013-10-01)

Scientific and regulatory approaches to confirm quality and improve patient perceptions of generic drug products in Japan
by: Hiroko Shibata, et al.
Published: (2016-10-01)

Changes in concentrations of antiepileptic drugs in pregnant women – a case report
by: Maria Jolanta Stanosz-Sankowska, et al.
Published: (2019-05-01)

Hormonal Contraception, Seizures, and Antiepileptic Drugs
by: Dilek ATAKLI
Published: (2018-01-01)

Economic evaluation of generic inhalational bronchodilators from the Jan-Aushadi scheme versus branded alternatives
by: Jerin James, et al.
Published: (2025-09-01)

Bioequivalence study of generic nirmatrelvir in healthy volunteers
by: R. A. Oseshnyuk, et al.
Published: (2023-05-01)

Correlation of reference and generic fluconazole-based drugs
by: A. S. Dukhanin
Published: (2020-04-01)

PROBLEM OF GENERIC REPLACEMENT: ADVANTAGES AND DISADVANTAGES
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

Bioequivalence evaluation of generic febuxostat versus Feburic® in healthy Chinese subjects: a randomized crossover study
by: Fengling Wang, et al.
Published: (2025-10-01)

Effect of Antiepileptic Drug Treatment on Thyroid Hormone Levels in Epilepsy Patients
by: Aytül Mutlu
Published: (2019-06-01)

Advances in pharmacogenomics: optimizing antiepileptic drug therapy for drug-resistant epilepsy
by: Amna Shahid, et al.
Published: (2024-05-01)

The effect of antiepileptic drugs on cognitive functions
by: A. S. Kotov
Published: (2013-12-01)

Intractable Seizures after Antiepileptic Withdrawal
by: J Gordon Millichap
Published: (2005-04-01)

Regulatory requirements for the registration of generic medicines and format of drug dossiers: procedures in Sri Lanka in comparison with selected regulatory authorities
by: D. Thambavita, et al.
Published: (2018-12-01)